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Tumorigenesis is a multistep process involving somatic mutations or epigenetic
changes affecting tumor suppressor and oncogenes.1,2 Additional genetic alterations create
a permissive environment for clonal expansion of cells that are resistant to apoptosis.
Advanced forms of common malignancies, such as colorectal, gastric, prostate or breast
carcinoma are often associated with poor responses to adjuvant chemotherapy (CT) and/
or ionizing radiation (IR).3 Apoptosis is a prominent mechanism for cell death following
CT or IR.4 Accordingly, considerable attention has been given to the Bcl‑2 family genes
as possible regulators of intrinsic tumor resistance to therapy.5 Repressors of programmed
cell death, such as Bcl‑2 and Bcl‑xL, decrease IR‑ and CT‑induced apoptotic cell death in
cell culture.6 However, key cellular factors that regulate expression of anti‑apoptotic genes
in tumors remain unknown. Defining dominant pathways responsible for modulation of
apoptosis‑regulating proteins would significantly enhance our understanding of tumor
behavior and could broaden current strategies for therapeutic intervention.
The regenerating (Reg) genes constitute a family belonging to calcium dependent
(C‑type) lectin gene superfamily.7‑10 The Reg family genes included six members (Reg I,
Reg II, Reg IIIa, Reg IIIb, Reg IIId and Reg IIIg) in the mouse and three members (Reg
Ia, Reg Ib and Reg III) in humans.11 Human Reg IV, a novel member of the family was
identified by high throughput sequencing of a library derived from patients with ulcerative
colitis, constituting fourth member of the Reg gene family in human.10 A mouse homologue has also been identified constituting the seventh member in mouse. Expression of
Reg genes is increased following injury, supporting a potential role in tissue repair and
regeneration.12,13 Expression of Reg proteins by colorectal, gastric, and pancreatic adenocarcinomas have recently been shown to have an adverse association with patient survival.14‑16
Reg IV was among several genes with increased expression in cancer cell lines selected for
increased in vitro resistance to the chemotherapeutic agent, 5‑FU.6 Reg IV expression was
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Expression of anti‑apoptotic genes is frequently elevated in tumors, where they increase
resistance to chemotherapeutic agents and predict poor patient outcomes. However, key
cellular factors regulating anti‑apoptotic genes in tumors remain unknown. Increased
expression of the regenerating (Reg) genes is commonly observed in gastrointestinal
(GI) malignancies including colorectal cancer (CRC). We therefore examined Reg gene
expression and associated changes in anti‑apoptotic genes in an animal model of GI
tumorigenesis. Using real time RT‑PCR, we measured expression of Reg genes in human
colorectal adenocarcinoma specimens, colon adenocarcinoma cell lines and adenomas
from multiple intestinal neoplasia (min) mice heterozygous for a germ‑line mutation of
the adenomatous polyposis coli (APC) gene. Expression of Reg genes is increased in
human colorectal adenocarcinomas and in the intestine of APCmin/+ mice at four weeks
of age, a time preceding the spontaneous second mutation in the APC gene. Individual
Reg genes exhibited regional expression profiles across the GI tract in mice. Adenomas
from 14‑week old mice had significant increases in at least one member of the Reg gene
family, most commonly Reg IV and an associated increase in expression of the anti‑apop‑
totic gene, Bcl‑2. Addition of exogenous recombinant human Reg IV to human colon
adenocarcinoma cells significantly increased Bcl‑2 and Bcl‑xL expression and induced
resistance to ionizing radiation. These results show that dysregulation of Reg genes occur
early in tumorigenesis. Furthermore, increased expression of Reg genes, specifically
Reg IV contribute to adenoma formation and lead to increased resistance to apoptotic
cell death in CRC.
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associated with intestinal differentiation in gastric adenocarcinoma17
and highly elevated in colorectal cancer (CRC).18,19 Reg IV has
also been identified as a promising marker of hormone refractory
metastatic prostate cancer.20 Recently we observed the mitogenic
effect of Reg IV protein, when added to the cultures of human colon
adenocarcinoma cell lines with subsequent changes in expression
of genes associated with altered apoptosis and metastasis.21 This
supports the hypothesis that Reg gene products are responsible for
altered apoptosis associated with a more aggressive tumor phenotype. Here we examined the expression of individual Reg genes in
human colorectal adenocarcinoma specimens and adenomas from
multiple intestinal neoplasia (Min) mice heterozygous for a germ‑line
nonsense mutation of the adenomatous polyposis coli (APC) gene.
These animals spontaneously develop multiple polyps in the small
and large intestine at 10–12 weeks of age following spontaneous
second mutation in the APC gene. This study shows specific regional
expression profiles of Reg genes along the cranio‑caudal axis of the
GI tract. Our results identify aberrant expression of the Reg genes as
one of the earliest events in gastrointestinal tumorigenesis. Reg IV
was specifically upregulated at the time of adenoma formation and
contributed to the increased resistance to apoptotic cell death.

Materials and Methods
Cell lines and culture. HCT116 and HT29 colon adenocarcinoma cells (American Type Culture Collection, Manassas, VA)
were grown in Dulbecco’s modified Eagle’s medium (Cambrex,
Walkersville, MD) containing 10% heat inactivated fetal bovine
serum (Sigma, St. Louis, MO). Cells were placed in serum‑free
media overnight prior to treatment with endotoxin‑free recombinant
human Reg IV (rhR4).22
Table 1
Gene

Human colorectal carcinoma specimens. Five millimeter sections
and total RNA isolated from human colorectal adenocarcinoma
specimens and paired normal mucosa were obtained from the Tissue
Procurement Core of the Siteman Cancer Center, Washington
University.
Animals. Breeding pairs of C57Bl/6j APCmin/+ mice were obtained
from Jackson Laboratories (Bar Harbor, ME). Mice were maintained
on a 10% fat diet (Harlan Teklad, Madison, WI). Young APCmin/+
mice were genotyped as previously described.23
Immunohistochemistry. Immunohistochemical staining of
human colorectal adenocarcinoma specimens and adenoma isolates
from APCmin/+ mice was performed by using previously characterized
antibodies against Reg IV22 and Bcl‑2 (Transduction laboratory, BD
Biosciences, Franklin lakes, NJ) in the Digestive Disease Research
Center Histopathology Core.
Real time RT‑PCR analysis. Total RNA isolated from human
colorectal adenocarcinoma isolates and paired normal mucosa,
adenomas from APCmin/+ and their wild‑type littermates (APC+/+)
and human colon adenocarcinoma cells (HCT116 and HT29) was
converted to cDNA using Superscript II reverse transcriptase and
random hexanucleotide primers (Invitrogen, Carlsbad, CA). Samples
were analyzed by real time RT‑PCR using Jumpstart Taq DNA
polymerase (Sigma, St. Louis, MO) and SYBR Green nucleic acid
stain (Molecular Probes, Eugene, Oregon) or Taqman probes (IDT,
Coralville, IA) for individual genes. Crossing threshold values for
individual genes were normalized to GAPDH (murine) or b‑Actin
gene expression. Probe and primer sets used for real time RT‑PCR
analysis are shown in Table 1.
Western blot analysis. Cell lysates from HCT116 and HT29
cells were subjected to PAGE electrophoresis and blotted on
to ImmobilinTM‑PVDF membranes (Millipore, Bedford, MA).

Probe and primer sets for Real Time RT-PCR
Species*

Primer

Probe & dye

GAPDH
M
GGCAAATTCAACGGCACAGT AGATGGTGATGGGCTTCCC
			

JOE/AGGCCGAGAATGGGAAGCTTGTCAC/		
BHQ

b Actin

H&M

ATCATTGCTCCTCCTGAGCG (F) GCTGATCCACATCTGCTGGAA (R)

SYBR

Reg I

M

CATCCTGCTCTCATGCCTGAT (F) GCAGATGGCAGGTCTTCTTCA (R)

TET/CCTGTCTCCAAGCCAAGGCCAGG/BHQ

Reg Ia

H

TGATGTTCCTGTCTCTGAGCCA (F) CCTTCTGGGCAGCTGATCC (R)

SYBR

Reg Ib

H

TCTGAGCCAAGGCCAGGA (F) GCCTTCTGGGCAGCTGATT (R)

SYBR

Reg II
M
ACAGCCAAGGCCAGGTAGCT (F) GGGCAGTTGATTTTGGCAGA (R)
			
Reg III

H

FAM/ACTTCCCCTTGGCTGAAAAAGACCTTCC/
BHQ

GTAACAGCTACTCATACGTCTGGA TTG (F) CTCCCAACCTTCTCCATTGG (R) SYBR

Reg IIIa
M
GGATTGGGCTCCATGATCC (F) TCAGCACATCGGAGTTACTCCA (R)
			

FAM/CCTCCATTGGGRTGTTGACCCATTGT/		
BHQ

Reg IIIb

TET/TGGTTTGATGCAGAACTGGCCTGC/BHQ

M

TGCCTTGTTTCAGATACCACAGA (F) GGTGTCCTCCAGGCCTCTTT (R)

Reg IIId
M
GTGTTGCCTGATGTCCCTTTC (F) CAGCTGATGCGTGGAGAAGAC (R)
			

FAM/TTTCTGGGATTGTTCACCTTGTACCCA/		
BHQ

Reg IIIg

TET/TGGGCTCCATGACCCGACACTG/BHQ

M

GGTAACAGTGGCCAATATGTA TGG (F) CCACCTCTGTTGGGTTCATAG (R)

Reg IV
M
CGTGCGGCTACTCTTACTGCT (F) AGCTGGGTCTCAAGATATCGCT (R)
			

FAM/CTGGGTAGCTGGCCCCGAAGTCC/		
BHQ

Reg IV

H

TGAGCTGCCTGGCCAAA (F) AAGTAACCATAGCAATTGGACTT GTG (R)

SYBR

Bcl 2

M

TGGATCCAGGATAACGGAAG (F) CAAACAGAGGTCGCATGCTG(R)

SYBR

Bcl 2

H

CGGTCTCCTGGTGCCATTAT (F) GAAACGTCACCTGCCCCC (R)

SYBR

Bcl xL

H

CCCATGCTCCGTTATCCTG (F) TAAGTCGCCATCCAAGCTGC (R)

SYBR

*H, human; M, murine.
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Statistical Analysis. Values were expressed as the mean ± s.e.m.
Data were analyzed by 2‑tailed t test. A p‑value of less than 0.05 was
considered as statistically significant.

Results

Figure 1. Reg IV is the dominant member of Reg gene family upregulated
in human colorectal adenocarcinomas. (A) Absolute mRNA expression of
Reg Ia, Reg Ib, Reg III and Reg IV genes was determined in 14 surgically resected
human colorectal adenocarcinomas specimens and paired normal mucosa.
Expression level of Individual Reg gene was normalized to 1000 arbitrary
units of b‑actin gene expression and plotted on logarithmic scale. Expression
profile shows that Reg IV is the dominant member of Reg family expressed at
higher level in normal mucosa and further increased in colorectal adenocarci‑
nomas. (B) Relative to normal mucosa, fold change in expression of Reg genes
was determined for individual colorectal adenocarcinoma specimens. 100%,
86%, 86% and 71% of colorectal adenocarcinoma specimens demonstrated
increased Reg IV, III, Ia and Ib expression respectively greater than 1.5‑fold.
(C) Immunohistochemical staining of adenocarcinoma isolates demonstrated
increased expression of Reg IV protein. Representative sections demonstrate
strong expression of Reg IV by a subset of cells with goblet‑like morphology
(left panel) in normal mucosa and staining by all cells (middle and right
panels) in adenocarcinomas.

Antibodies were purchased from Transduction laboratory (BD
Biosciences, Franklin Lakes, NJ) and Santa Cruz Biotechnology (Santa
Cruz, CA). Specific proteins were detected by enhanced chemiluminescence (ECL) (Amersham Pharmacia Biotech, Piscataway, NJ).
In vitro radiation‑survival colony assay. HCT116 and HT29
cells were plated at 104 cells/25 cm2 flasks and incubated in serum
containing media overnight to allow cell adherence. Cultures were
then incubated in serum free media with or without 100 nM rhR4.
After 18 hours, cells were subjected to either 0 or 4 Gy g‑irradiation
(IR) in a Gamacel 40 cesium irradiator at 0.96 cGy/min. Cells were
allowed to grow until the development of microscopically visible
colonies.
1716

Reg IV is most upregulated gene of Reg family in human
colorectal adenocarcinomas. In order to determine Reg gene expression in gastrointestinal tumors, we measured the expression of human
Reg genes in 14 colorectal adenocarcinoma resection specimens and
paired normal mucosa. mRNA expression of individual Reg genes
was determined by real time RT‑PCR and normalized to b‑Actin
expression. Absolute mRNA level of individual Reg gene was determined based on titrated standard curve using specific primer sets and
probes. Reg IV was the dominant member of the Reg gene family
expressed in normal mucosa (mRNA expression: 6.1 ± 4.5, 0.45
± 0.2, 0.05 ± 0.03, and 27.2 ± 9.3 of Reg Ia, Reg Ib, Reg III and
Reg IV respectively) (Fig. 1A). While colorectal adenocarcinoma
specimens exhibited increased expression of all Reg genes, Reg IV,
and to a lesser extent Reg Ia constituted the dominant members of
the Reg gene family expressed by colorectal adenocarcinomas (mRNA
expression: 492 ± 304, 56 ± 33, 8 ± 6, and 1456 ± 676 of Reg Ia, Reg
Ib, Reg III and Reg IV respectively) (Fig. 1A). Individual resected
tumors showed highly unique patterns of Reg gene expression. For
example, specimen 3 had increased Reg IV expression only, however,
specimen 2 had increases in expression of all members of the Reg gene
family including Reg IV. 100%, 86%, 86%, and 71% of colorectal
adenocarcinoma specimens demonstrated increased Reg IV, III, Ia,
and Ib expression respectively, greater than 1.5‑fold relative to adjacent normal mucosa (Fig. 1B). No clear correlation between levels of
Reg gene expression and a particular histopathology or tumor stage
was observed (data not shown). Consistent with increased Reg IV
mRNA, colorectal adenocarcinomas showed prominent expression of
Reg IV protein by immunohistochemistry (Fig. 1C).
Expression of Reg genes is dysregulated early in tumorigenesis.
We first characterized the expression of the Reg gene family in the
normal murine GI tract. Total RNA was isolated from individual
segments of the GI tract, extending from the stomach to the colon of
14‑week old mice. Reg gene expression was then determined by using
Taqman probe and primer sets specific for each of the 7 Reg genes
in the murine genome. Individual Reg genes displayed one of three
embryologically‑derived expression patterns across the cranio‑caudal
axis of the adult GI tract (Fig. 2A). Reg I, II and IIId had maximal
expression in the foregut‑derived stomach and duodenum; Reg IIIa,
IIIb, and IIIg in midgut‑derived small bowel extending from the
jejunum to the ileum, whereas Reg IV was unique with prominent
expression in the cecum and colon. We next utilized APCmin/+ mice
to determine at what step expression of individual Reg genes becomes
dysregulated during tumorigenesis. We analyzed regional expression
of different Reg genes in the intestines of four‑week old APCmin/+
mice and wild‑type (APC+/+) littermate controls. four‑week old
wild‑type APC+/+ mice had regional expression patterns mirroring
that shown in 14‑week normal adults (data not shown). Compared
to wild‑type APC+/+ mice, different intestinal segments of four‑week
old APCmin/+ mice showed significant increases in expression of all
Reg genes, except Reg IV (Fig. 2B). Intestinal regions associated
with the greatest predisposition for adenomatous polyp formation
had increases of greater than two‑fold in Reg I, II, IIIb and IIIg
expression. Furthermore, segmental increases were seen in both Reg
members expressed normally at that site (e.g., Reg IIIb in the ileum)
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Figure 2. Reg gene expression varies regionally in the normal murine GI tract
and is dysregulated in 4‑week old APCmin/+ mice. (A) Taqman probe and
primer sets specific to individual murine Reg genes were used to determine
antero‑posterior expression of Reg gene family in the GI tract of normal mice.
Total RNA isolated from the stomach (ST), duodenum (DU), proximal jejunum
(PJ), distal jejunum (DJ), ileum (IL), cecum (CE), proximal colon (PC) and distal
colon (DC) were used for reverse transcriptase reactions (n = 5). Expression
of Reg genes is plotted as relative expression (%) in the gastrointestinal tract
by considering highest level as 100. Expression profiles fall into three region‑
ally distinct patterns: foregut (left panel); Reg I, Reg II and Reg IIId, midgut
(right panel); Reg IIIa, Reg IIIb, and Reg IIIg, or hindgut (left panel); Reg IV.
(B) 4‑week old APCmin/+ mice and wild‑type APC+/+ littermates were used to
precisely determine when Reg gene expression becomes dysregulated in a
model of GI tumorigenesis. Total RNA isolated from the adenoma from DJ, IL,
CE, and PC segments of four‑week old APCmin/+ mice and wild‑type APC+/+
littermate was used for reverse transcriptase reactions (n = 6). At four weeks
of age, increases in Reg gene expression in APCmin/+ mice precede the
second spontaneous mutation in the APC gene and histopathologic adenoma
formation.

as well as Reg genes not expressed at that location (e.g., Reg II and
IIIg). Further, to determine changes in Reg gene expression associated
with adenoma development, visible adenomas and adjacent normal
mucosa were microdissected from 14‑week APCmin/+ mice. Cox‑2
expression was used as a marker for successful adenoma isolation.
Reg IV represented the most commonly increased member of the
family in 19 individual adenomas when compared to their adjacent
normal mucosa (≥1.5 fold in 72% of adenomas) (Fig. 3). Similar
expression profiles of individual Reg genes were also observed in each
adenoma examined, mirroring human colorectal adenocarcinoma
specimens.
Reg IV regulates anti‑apoptotic genes. Increased Bcl‑2 and Bcl‑xL
expression is a frequent occurrence in colon adenocarcinomas and is
predictive of poor prognosis.24 To show an upregulation of Bcl‑2 in
APCmin/+ mice, we examined Bcl‑2 expression in adenomas by immunohistochemistry (Fig. 4A). In 14‑week old wild‑type APC+/+ mice
(WT), staining was largely confined to the lamina propria immune
www.landesbioscience.com

Figure 3. Reg IV is the most frequently upregulated member of Reg gene
family in microdissected adenomas from 14‑week old APCmin/+ mice.
Adenoma development occurs following a spontaneous mutation in the sec‑
ond copy of the APC gene. The expression of individual murine Reg genes
were determined using RNA isolated from microdissected adenomas and
adjacent normal mucosa (n = 19). Cox‑2 mRNA was also measured as a
marker for effective adenoma isolation. Eighteen of the nineteen adenoma
samples demonstrated increased Cox‑2 mRNA as expected. Fold increase
for individual Reg genes compared to adjacent normal mucosa are indi‑
cated. Similar to human colorectal adenocarcinomas, individual adenoma
demonstrated increased expression of at least one member of the Reg gene
family. Reg IV represented the most commonly increased member of the
family (≥1.5 fold in 72% of adenomas).

cell populations (left panel). Epithelial staining in macroscopically
normal appearing mucosa from APCmin/+ mice (mAde) was restricted
to microadenomas (middle panel). However, the epithelium in
microdissected gross adenomas from APCmin/+ mice (Ade) was globally stained for Bcl‑2 (right panel). Bcl‑2 mRNA expression was
also increased in adenomas and closely paralleled changes in Bcl‑2
protein staining (Fig. 4B). The pronounced increase in Bcl‑2 mRNA
occurred coincides with the development of macroscopic adenomas.
In addition, adenomas from 14‑week APCmin/+ mice with increased
Reg IV expression generally demonstrated an associated increase in
Bcl‑2 mRNA (Fig. 4C). To establish a causative association between
Reg IV and anti‑apoptotic genes, 100 nM rhR4 was added to cultures
of human colon adenocarcinoma cell lines (Fig. 5). Bcl‑2 and Bcl‑xL
mRNA expression in HCT116 (left panel) and HT29 (right panel)
cells were determined by real time RT‑PCR analysis. Bcl‑2 expression
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Figure 4. Bcl‑2 expression is increased in microdissected adenomas from 14‑week APCmin/+ mice. (A) Representative sections demonstrate normal ileum from
14‑week old wild‑type APC+/+ mice (normal) showing prominent Bcl‑2 staining (arrowheads) in lamina propria immune cell populations but not in epithelial
cells (left panel), ileac microadenoma from 14‑week APCmin/+ mice (microadenoma) showing strong Bcl‑2 staining of the adenoma (arrowheads) but in the
normal surrounding epithelium (middle panel), and ileac gross adenomas from 14‑week APCmin/+ mice (adenoma) showing global staining of epithelium
cells (right panel). (B) Relative to normal mucosa from wild‑type APC+/+ mice (WT), Bcl‑2 mRNA expression is increased in histologically normal mucosa
(mAde) and adenomas (Ade) from 14‑week APCmin/+ mice (n = 5). A pronounced increase in Bcl‑2 mRNA occurs coincident with the development of frank
adenomas. (C) Relative to histologically normal mucosa, fold increases in Reg IV and Bcl‑2 expression in adenomas from 14‑week APCmin/+ mice were used
to determine correlation between these two genes. Adenomas from APCmin/+ mice with increased Reg IV expression demonstrated an associated increase
in Bcl‑2 mRNA (Correlation coefficient, R2 = 0.716).
Figure 5. Reg IV treatments increase anti‑apoptotic genes, Bcl‑2 and Bcl‑xL
in human colon adenocarcinoma cells. (A) HCT116 and HT29 human colon
adenocarcinoma cell monolayer were treated for various times (h) with 100
nM rhR4. SYBR green nucleic acid dye and specific primer sets were used to
determine mRNA expression of Bcl‑2 and Bcl‑xL. Addition of rhR4 to HCT116
cells (left panel) and HT29 cells (right panel) significantly increased Bcl‑2 and
Bcl‑xL gene expression (*p < 0.05). B) Western blot showing Bcl‑2 and Bcl‑xL
protein expression at various times (h) following addition of 100 nM rhR4 to
HCT116 (left panel) and HT29 cells (right panel). Lower panel indicates the
intensity of bands by densitometry scanning. Treatments of rhR4 to HCT116
and HT29 cells led to increased expression of Bcl‑2 and Bcl‑xL proteins and
demonstrated parallel changes to their respective mRNA expression.

was increased significantly following rhR4‑treatment for 2 h in
HCT116 and 1 h in HT29 cells (Fig. 5A). In addition, significant
increases in Bcl‑xL expression were observed, when rhR4 was added
to the culture medium of HCT116 cells for 2 h and HT29 cells for
3 h (Fig. 5A). To determine if the increases in Bcl‑2 and Bcl‑xL
mRNA were associated with changes in protein expression, western
blotting was performed on cell lysates isolated following rhR4
treatment. Corresponding increases in Bcl‑2 and Bcl‑xL protein
1718

were observed in HCT116 and HT29 cells (Fig. 5B). In response to
rhR4‑treatments, increases in Bcl‑2 expression occurred earlier than
that of Bcl‑xL. These data show that exogenous Reg IV regulates
expression of Bcl‑2 and Bcl‑xL genes and supported our previous
finding of increased expression of anti‑apoptotic genes in response
to elevated level of Reg IV protein in colorectal adenocarcinoma
cells.21
Reg IV treatment induces cell survival against radiation‑
induced apoptosis. Repressors of programmed cell death may
directly increase resistance to therapy‑induced cell death. We therefore investigated a possible protective role of Reg IV in human colon
adenocarcinoma cells using an in vitro radiation‑survival colony
assay (Fig. 6). HCT116 and HT29 cells grown on culture plates
containing media with or without 100nM of rhR4 were exposed
to 4 Gy IR. The microscopically visible colonies in this model are
reflective of a single surviving and proliferating cell. Exogenous
Reg IV treatment significantly increased the number of colonies.
Following 4 Gy IR, colony counts increased from 34.8 ± 5.1 to
50.4 ± 3.5 (45% increase, p < 0.05) in HCT116 (left panel) and
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Figure 6. In vitro radiation‑survival colony assay showing decreases in
radiation‑induced apoptosis following rhR4 treatment in human colon
adenocarcinoma cells. HCT116 (left panel) and HT29 cells (right panel)
were plated at 104cells/25 cm2 flask and incubated overnight to allow cell
adherence. Cultures were then treated with complete media with or without
100 nM rhR4. After 18 hours cells were subjected to either 0 or 4 Gy IR and
allowed to grow until the development of visible colonies. Colonies counted
reflects survival and proliferation of individual cells (lower panel). Addition
of rhR4 to HCT116 and HT29 cells significantly increased the number of
surviving cells following 4 Gy IR (A and C, p < 0.05, control vs. 4 Gy IR; B
and D, p < 0.05, 4 Gy IR vs. 4 Gy IR + rhR4 with HCT116 and HT29 cells
respectively).

36.8 ± 3.5 to 60.3 ± 5.7 (64% increase, p<0.005) in HT29 cells
(right panel). In the absence of IR, rhR4 treatment did not result in a
difference in the number of colonies. This data indicates that Reg IV
promotes tumor cell survival following a potent apoptotic stimulus.

Discussion
Most adenocarcinomas are relatively resistant to CT and IR.25‑27
Efforts to overcome this resistance by increasing concentration of
cytotoxic drugs or dosage of irradiation has been failed to significantly improve the therapeutic response. Apoptosis is a prominent
mechanism for death of cancer cells following CT or IR.4,26 Novel
cancer treatment strategies targeting the genes that promote apoptosis or blocking factors that inhibit apoptosis may prove adjuvant in
the treatment of many malignancies. The expression of the Reg gene
family is increased in common malignancies including colorectal,
gastric, hepatocellular and pancreatic adenocarcinomas and may have
an adverse association with patient outcomes or survival.14‑17,28 We
observed increased expression of all genes of Reg family in a series of
human colorectal adenocarcinoma specimens. Reg IV was the most
upregulated member of the family in these specimens. This was in
accordance with previously reported data showing elevated expression of Reg IV in colorectal carcinomas.18,19
The multistep tumorigenesis model proposed by Vogelstein and
Fearon describes step‑wise transformation from the benign polyp to
the malignant phenotype of colorectal cancer.1,2 A similar multistep
process was also observed in a hepatocarcinogenesis model in rats.29
In each of these models, it appears that tumorigenesis is associated
with an increased cell proliferation and an associated decrease in
apoptotic cell death. It is likely that a variety of cellular pathways may
www.landesbioscience.com

contribute to decreased apoptosis at specific stages of tumorigenesis.
This may also be required for the development of a malignant phenotype. The APCmin/+ mouse model was chosen, because it mimics
the developmental process of human GI tumorigenesis. These mice
spontaneously develop multiple adenomas in small and large intestine at around 10–12 weeks of age following a second spontaneous
mutation in the APC gene. Compared to wild‑type littermate controls
(APC+/+), four‑week old APCmin/+ mice already had significant
increases in expression of Reg genes, preceding the second spontaneous
mutation in the APC gene. However, increased Reg IV expression
was not detected prior to the polyp formation or adenomatous
changes by histology. Significant increases in Reg IV expression
were noted in a series of adenomas microdissected from 14‑week
old APCmin/+ mice. This data is first of its kind to demonstrate that
the Reg IV might have a potential role during adenoma formation
following second spontaneous mutation in APC gene. These data also
demonstrated that adenoma formation was associated with increased
expression of at least one Reg gene, mirroring the results observed
in human colorectal adenocarcinomas. Our results in the APCmin/+
mouse model are in agreement with findings of a 2–3 fold increase
in Reg IV expression in flat colonic mucosa containing microscopic
adenomatous changes in three patients with familial adenomatous
polyposis (data not shown).
Increases in Reg IV expression in adenomas of 14‑week old
APCmin/+ mice had an associated increase in Bcl‑2 expression.
Human colorectal adenocarcinoma specimens with increased Reg IV
expression exhibited increased expression of Bcl‑2 and Bcl‑xL mRNA
(data not shown). A causative role for Reg IV in regulation of the
Bcl‑2 family genes has been confirmed with increased expression of
Bcl‑2 and Bcl‑xL at mRNA and prtotein levels following addition of
rhR4 to culture media of human colon adenocarcinoma cell lines.
This result supported our previous finding of increased expression
of anti‑apoptotic genes via Reg IV‑mediated EGFR/Akt signaling
cascades.21 Furthermore, addition of rhR4 to human colon adenocarcinoma cells led to significantly greater resistance to cell death
following IR. Functional blocking of Reg IV protein increased cell
susceptibility to IR‑induced death (data not shown). Collectively,
these data suggest that up‑regulation of Reg IV and corresponding
changes in cellular predisposition to apoptosis may play a requisite
early role in adenoma formation.
In summary, individual Reg genes show a specific expression
profile along the canio‑caudal axis of the GI tract. The expression of
Reg genes is increased in colorectal adenocarcinoma and constitutes
an early event in intestinal tumorigenesis in APCmin/+ mice. While
the APCmin/+ mouse model does not completely recapitulate human
colon cancer given the expression of polyps in both the small bowel
and colon, the model offers the unique opportunity to study genetic
changes occurring at a premalignant stage, before more profound
genetic derangements and clonal selection pressures. Increased
Reg IV expression might lead to a tumor phenotype displaying
increased resistance to apoptotic cell death. These results identify
Reg proteins as previously unappreciated regulators of anti‑apoptotic
proteins in early tumorigenesis and may contribute to increased
resistance to apoptotic death during therapy. Strategies designed to
reduce endogenous Reg expression or block downstream signaling
warrant further investigation for use in the prevention or treatment
of established gastrointestinal adenocarcinomas.
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